ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,137,150 | +17246.4% | 635,000 | -66.2% | 0.78% | -82.5% |
| Q4 2022 | $29,615 | -99.9% | 1,880,286 | -22.0% | 4.46% | -26.8% |
| Q3 2022 | $37,943,000 | +12.8% | 2,410,622 | 0.0% | 6.10% | -14.3% |
| Q2 2022 | $33,652,000 | -15.7% | 2,410,622 | +4.1% | 7.12% | -20.2% |
| Q1 2022 | $39,905,000 | +2.7% | 2,314,648 | -13.4% | 8.91% | -1.0% |
| Q4 2021 | $38,856,000 | -1.4% | 2,672,346 | +22.0% | 9.00% | -13.4% |
| Q3 2021 | $39,425,000 | +34.5% | 2,190,291 | +31.2% | 10.39% | +1.8% |
| Q2 2021 | $29,307,000 | +13.1% | 1,668,987 | +62.3% | 10.21% | -1.1% |
| Q1 2021 | $25,908,000 | +199.7% | 1,028,084 | -23.1% | 10.32% | +119.5% |
| Q4 2020 | $8,646,000 | – | 1,336,275 | – | 4.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |